These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23200317)

  • 1. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
    Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
    J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
    Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
    J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
    Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
    J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 2D6 as a model antigen.
    Christen U; Holdener M; Hintermann E
    Dig Dis; 2010; 28(1):80-5. PubMed ID: 20460894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CYP2D6 animal model: how to induce autoimmune hepatitis in mice.
    Hintermann E; Ehser J; Christen U
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aetiopathogenesis of autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
    Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
    Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.
    Holdener M; Hintermann E; Bayer M; Rhode A; Rodrigo E; Hintereder G; Johnson EF; Gonzalez FJ; Pfeilschifter J; Manns MP; Herrath Mv; Christen U
    J Exp Med; 2008 Jun; 205(6):1409-22. PubMed ID: 18474629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adenovirus-induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model.
    Fuchs S; Bayer M; Taubert R; Manns MP; Pfeilschifter JM; Christen U; Hintermann E
    Liver Int; 2019 Dec; 39(12):2330-2340. PubMed ID: 31225929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
    Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
    J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive immunity in autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New animal models for autoimmune hepatitis.
    Christen U; Hintermann E; Jaeckel E
    Semin Liver Dis; 2009 Aug; 29(3):262-72. PubMed ID: 19675999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.
    Ma Y; Bogdanos DP; Hussain MJ; Underhill J; Bansal S; Longhi MS; Cheeseman P; Mieli-Vergani G; Vergani D
    Gastroenterology; 2006 Mar; 130(3):868-82. PubMed ID: 16530525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different sites of xenoantigen delivery lead to a virally induced late-onset hepatitis in mice through molecular mimicry.
    Piché C; Béland K; Lapierre P; Massie B; Alvarez F
    Liver Int; 2011 Oct; 31(9):1306-14. PubMed ID: 22093453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
    Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
    Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators?
    Vierling JM
    Hepatology; 2011 Feb; 53(2):385-8. PubMed ID: 21274860
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
    Longhi MS; Hussain MJ; Bogdanos DP; Quaglia A; Mieli-Vergani G; Ma Y; Vergani D
    Hepatology; 2007 Aug; 46(2):472-84. PubMed ID: 17559153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
    Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
    J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.